Atara Biotherapeutics, Inc.
ATRA· Nasdaq
Released Nov 5, 2015, after the close
10-Q filed Nov 6, 2015, 37 days after period end · 0001564590-15-009779
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|
| Net Income | -$11.87M | -$5.92M | -$2.54M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Atara Biotherapeutics, Inc. · CIK 1604464 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Nov 6, 2015 · 37 d after period end
+9.5% from the close of Nov 5, 2015 to the close of Nov 6, 2015, the first after the release.